Ashton C. Berger

40.4k total citations
13 papers, 440 citations indexed

About

Ashton C. Berger is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ashton C. Berger has authored 13 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Ashton C. Berger's work include Cancer Genomics and Diagnostics (5 papers), Cancer-related gene regulation (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). Ashton C. Berger is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Cancer-related gene regulation (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). Ashton C. Berger collaborates with scholars based in United States, Switzerland and Israel. Ashton C. Berger's co-authors include Andrew D. Cherniack, Matthew Meyerson, Galen F. Gao, Jonathan T. Goldstein, Francisca Vázquez, Aviad Tsherniak, Peter S. Choi, Juliann Shih, William C. Hahn and Tao Zou and has published in prestigious journals such as Nature, Nature Communications and Bioinformatics.

In The Last Decade

Ashton C. Berger

12 papers receiving 435 citations

Peers

Ashton C. Berger
Davide Schiavone Italy
Jinliang Huan China
Jian-Chun Cai China
Martin Hellriegel Germany
Anita Klous Netherlands
Weimei Tang China
Da Huang China
Daniel E. Foxler United Kingdom
Deyang Li China
Stavros Milatos Greece
Davide Schiavone Italy
Ashton C. Berger
Citations per year, relative to Ashton C. Berger Ashton C. Berger (= 1×) peers Davide Schiavone

Countries citing papers authored by Ashton C. Berger

Since Specialization
Citations

This map shows the geographic impact of Ashton C. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashton C. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashton C. Berger more than expected).

Fields of papers citing papers by Ashton C. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashton C. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashton C. Berger. The network helps show where Ashton C. Berger may publish in the future.

Co-authorship network of co-authors of Ashton C. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Ashton C. Berger. A scholar is included among the top collaborators of Ashton C. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashton C. Berger. Ashton C. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Stewart, Daniel, Becky K. Brisson, Ashton C. Berger, et al.. (2024). Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment. npj Breast Cancer. 10(1). 86–86. 7 indexed citations
2.
Shih, Juliann, Shahab Sarmashghi, Shu Zhang, et al.. (2023). Cancer aneuploidies are shaped primarily by effects on tumour fitness. Nature. 619(7971). 793–800. 46 indexed citations
3.
Gao, Galen F., Coyin Oh, Gordon Saksena, et al.. (2022). Tangent normalization for somatic copy-number inference in cancer genome analysis. Bioinformatics. 38(20). 4677–4686. 4 indexed citations
4.
Gibson, William J., Meredith S. Brown, Jack A. Kosmicki, et al.. (2020). Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities. Nature Communications. 11(1). 2517–2517. 67 indexed citations
5.
Taylor, Alison M., Juliann Shih, Gavin Ha, et al.. (2019). MS12.02 Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Journal of Thoracic Oncology. 14(10). S179–S179. 3 indexed citations
6.
Cherniack, Andrew D., Romualdo Barroso‐Sousa, Brittany Bychkovsky, et al.. (2019). Abstract PD9-01: Genomic alterations associated with loss of HR expression in metastatic breast cancer. Cancer Research. 79(4_Supplement). PD9–1. 1 indexed citations
7.
Gannon, Hugh, Tao Zou, Michael K. Kießling, et al.. (2018). Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. Nature Communications. 9(1). 5450–5450. 159 indexed citations
8.
Berger, Ashton C., Anil Korkut, Rupa S. Kanchi, et al.. (2018). Abstract 3303: A comprehensive TCGA Pan-Cancer molecular study of gynecologic and breast cancers. Cancer Research. 78(13_Supplement). 3303–3303. 2 indexed citations
9.
Paolella, Brenton R., William J. Gibson, Meredith S. Brown, et al.. (2018). Abstract 3003: Loss of heterozygosity of essential genes represents a novel class of cancer vulnerabilities. Cancer Research. 78(13_Supplement). 3003–3003. 1 indexed citations
10.
Zhang, Xiaoyang, Peter S. Choi, Joshua M. Francis, et al.. (2017). Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor. Cancer Discovery. 8(1). 108–125. 85 indexed citations
11.
Goldstein, Jonathan T., Ashton C. Berger, Juliann Shih, et al.. (2017). Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer. Cancer Research. 77(24). 6987–6998. 59 indexed citations
12.
Berger, Ashton C.. (2002). Helicobacter pylori breath tests. BMJ. 324(7348). 1263–1263. 6 indexed citations
13.
Berger, Ashton C.. (2000). Saliva test could diagnose cancers. BMJ. 320(7238). 825–825.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davide Schiavone Breakdown of academic impact, for papers by Jinliang Huan Breakdown of academic impact, for papers by Jian-Chun Cai Breakdown of academic impact, for papers by Martin Hellriegel Breakdown of academic impact, for papers by Anita Klous Breakdown of academic impact, for papers by Weimei Tang Breakdown of academic impact, for papers by Da Huang Breakdown of academic impact, for papers by Daniel E. Foxler Breakdown of academic impact, for papers by Deyang Li Breakdown of academic impact, for papers by Stavros Milatos
Rankless by CCL
2026